FDA’s Guidance on Postmarket Management of Cybersecurity in Medical Devices - Webinar CD/Transcript
FDA’s Guidance on Postmarket Management of Cybersecurity in Medical Devices
How can you protect your medical devices from ever-changing cybersecurity threats?
Join Nick Sikorski and Jongbum Keum — both of Deloitte & Touche LLP, – Cyber Risk Services — for a discussion on the final guidance on postmarket management of cybersecurity in medical devices which was released in Dec. 2016.
After this 90-minute session you’ll know:
- What the FDA’s recommendations are for managing postmarket cybersecurity vulnerabilities
- What manufacturers should monitor, identify, and address cybersecurity vulnerabilities and exploits as part of their postmarket management of medical devices
- How to establish a risk-based framework for assessing when changes to medical devices for cybersecurity vulnerabilities require reporting to the FDA
- Techniques for outlining circumstances in which the FDA does not intend to enforce reporting requirements under 21 CFR, part 806
Order today and get up-to-speed on what the new cybersecurity final guidance means for you.